119 related articles for article (PubMed ID: 15799254)
1. [Buprenorphine treatment during pregnancy--risk factors and advantages need to be considered carefully].
Strengell P; Vahtola M; Tammela O; Seppä K
Duodecim; 2005; 121(4):392-9. PubMed ID: 15799254
[No Abstract] [Full Text] [Related]
2. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Likar R; Kayser H; Sittl R
Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
[TBL] [Abstract][Full Text] [Related]
3. [Opioids in the treatment of pain--efficient weapon in the expert's hand].
Kalso E
Duodecim; 2004; 120(2):195-6. PubMed ID: 15065513
[No Abstract] [Full Text] [Related]
4. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
5. Anti-hyperalgesia properties of buprenorphine.
Russo MA
Pain; 2006 May; 122(1-2):216; author reply 216. PubMed ID: 16524662
[No Abstract] [Full Text] [Related]
6. [Buprenorphine matrix patch well tolerated. The challenge of tumor pain].
MMW Fortschr Med; 2006 Jan; 148(1-2):42-3. PubMed ID: 16612846
[No Abstract] [Full Text] [Related]
7. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
Griessinger N; Sittl R; Likar R
Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
[TBL] [Abstract][Full Text] [Related]
10. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.
Koppert W; Ihmsen H; Körber N; Wehrfritz A; Sittl R; Schmelz M; Schüttler J
Pain; 2005 Nov; 118(1-2):15-22. PubMed ID: 16154698
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
12. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
Sittl R; Nuijten M; Nautrup BP
Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
[TBL] [Abstract][Full Text] [Related]
13. High dose buprenorphine in pregnancy.
Ross D
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):80. PubMed ID: 15089877
[No Abstract] [Full Text] [Related]
14. Treating opioid dependency and coexistent chronic nonmalignant pain.
Blondell RD; Ashrafioun L
Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
[No Abstract] [Full Text] [Related]
15. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
Tschirner M; Ritzdorf I; Brünjes R
MMW Fortschr Med; 2008 Sep; 150 Suppl 3():142-8. PubMed ID: 19025217
[TBL] [Abstract][Full Text] [Related]
16. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
Barutell C; Camba A; González-Escalada JR; Rodríguez M;
Pain Pract; 2008; 8(5):355-61. PubMed ID: 18662364
[TBL] [Abstract][Full Text] [Related]
17. Prolonged epidural analgesia for intractable lumbo-sacral pain in pregnancy.
Khan M; Mahmood T
J Obstet Gynaecol; 2008 Apr; 28(3):350-1. PubMed ID: 18569491
[No Abstract] [Full Text] [Related]
18. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
[TBL] [Abstract][Full Text] [Related]
19. [Erroneous opinions refuted. New knowledge about an old effective substance].
MMW Fortschr Med; 2006 Jan; 148(1-2):42. PubMed ID: 16610414
[No Abstract] [Full Text] [Related]
20. High dose of buprenorphine in terminally ill patient with liver failure: efficacy and tolerability.
Ciccozzi A; Angeletti C; Baldascino G; Petrucci E; Bonetti C; De Santis S; Paladini A; Varrassi G; Marinangeli F
J Opioid Manag; 2012; 8(4):253-9. PubMed ID: 22941853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
